• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斯德哥尔摩乳腺钼靶筛查试验中的未参加情况:相对死亡率及未参加原因

Nonattendance in the Stockholm mammography screening trial: relative mortality and reasons for nonattendance.

作者信息

Lidbrink E, Frisell J, Brandberg Y, Rosendahl I, Rutqvist L E

机构信息

Department of Oncology, Söder Hospital, Stockholm, Sweden.

出版信息

Breast Cancer Res Treat. 1995 Sep;35(3):267-75. doi: 10.1007/BF00665978.

DOI:10.1007/BF00665978
PMID:7579497
Abstract

The first objective of this study was to analyze the survival rate in a group of 69 breast cancers detected among nonattenders in a randomized mammographic screening trial in relation to 142 clinically detected cancers in a nonscreened control population. By analyzing the cancers of the nonattenders we identified two subgroups, one (A) had actively avoided mammography, had cancers in more advanced stages on diagnosis, and had significantly higher mortality from breast cancer than the control group (p = 0.003). The second subgroup (B) had mammography done outside the screening program. This subgroup had a nonsignificant, slightly better survival (p = 0.19) compared to the control group. Concerning stage the cancers in group B were similar to the cancers by the screening program. The second objective was to analyze women's reasons for nonattendance in the screening program. We interviewed 200 randomly selected nonattenders; 33% stated that they never could imaging having mammography (definite nonattenders), 29.5% that they for various reasons had missed the mammography but could imagine having it next time (possible future attenders), and 32% had been examined outside the program. Reasons for nonattendance included disinterest, medical problems, and fear of X-rays. From this interview investigation we believe that the subgroup of definite nonattenders (33%) is difficult to influence. The second subgroup classified as possible future attenders (29.5%) we believe can be influenced by more information and a new opportunity to receive mammography, i.e., a reminder letter. The third subgroup, those examined outside the screening program (32%) were aware of the benefit of mammography, taking action on their own.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

本研究的首要目标是,分析在一项随机乳腺钼靶筛查试验中未参加者群体里检测出的69例乳腺癌的生存率,并与未筛查的对照人群中临床检测出的142例癌症进行对比。通过分析未参加者的癌症情况,我们识别出两个亚组,其中一个亚组(A)主动回避乳腺钼靶检查,诊断时癌症处于更晚期阶段,乳腺癌死亡率显著高于对照组(p = 0.003)。第二个亚组(B)在筛查项目之外进行了乳腺钼靶检查。与对照组相比,该亚组生存率虽无显著差异,但略高(p = 0.19)。就分期而言,B组的癌症与筛查项目中的癌症相似。第二个目标是分析女性不参加筛查项目的原因。我们随机采访了200名未参加者;33%表示她们根本无法想象自己会进行乳腺钼靶检查(明确的未参加者),29.5%称她们因各种原因错过了乳腺钼靶检查,但下次可以想象会去做(可能未来会参加者),32%在项目之外接受过检查。不参加的原因包括不感兴趣、医疗问题以及对X射线的恐惧。通过这次访谈调查,我们认为明确的未参加者亚组(33%)很难被影响。我们认为第二个被归类为可能未来会参加者的亚组(29.5%)可以通过更多信息以及接受乳腺钼靶检查的新机会,即提醒信,来加以影响。第三个亚组,即在筛查项目之外接受检查的那些人(32%)了解乳腺钼靶检查的益处,并自行采取了行动。(摘要截选至250词)

相似文献

1
Nonattendance in the Stockholm mammography screening trial: relative mortality and reasons for nonattendance.斯德哥尔摩乳腺钼靶筛查试验中的未参加情况:相对死亡率及未参加原因
Breast Cancer Res Treat. 1995 Sep;35(3):267-75. doi: 10.1007/BF00665978.
2
Factors affecting participation in mammography screening.影响乳腺钼靶筛查参与率的因素。
N Z Med J. 1996 Sep 27;109(1030):359-61.
3
Attitudes, beliefs, and knowledge as predictors of nonattendance in a Swedish population-based mammography screening program.态度、信念和知识作为瑞典基于人群的乳腺钼靶筛查项目中未参加筛查的预测因素。
Prev Med. 2000 Oct;31(4):417-28. doi: 10.1006/pmed.2000.0723.
4
The Stockholm breast cancer screening trial--5-year results and stage at discovery.
Breast Cancer Res Treat. 1989 Jan;13(1):79-87. doi: 10.1007/BF01806553.
5
Nonattendance in mammographic screening: a study of intraurban differences in Malmö, Sweden, 1990-1994.乳腺钼靶筛查中的未参与情况:对瑞典马尔默1990 - 1994年城市内部差异的研究
Cancer Detect Prev. 2001;25(2):132-7.
6
Cancer anxiety and attitudes toward mammography among screening attenders, nonattenders, and women never invited.筛查参与者、非参与者及从未被邀请过的女性的癌症焦虑与对乳房X光检查的态度
Am J Public Health. 1992 Feb;82(2):249-51. doi: 10.2105/ajph.82.2.249.
7
Interval cancer and survival in a randomized breast cancer screening trial in Stockholm.斯德哥尔摩一项随机乳腺癌筛查试验中的间期癌与生存率
Breast Cancer Res Treat. 1992;24(1):11-6. doi: 10.1007/BF01832353.
8
Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma.未参加乳腺癌筛查与不利的社会经济状况及晚期癌症相关。
Int J Cancer. 2004 Feb 20;108(5):754-60. doi: 10.1002/ijc.11622.
9
Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.50岁以下女性乳腺癌筛查:检测方式、发病率、死亡率及组织学情况
J Med Screen. 1995;2(2):94-8. doi: 10.1177/096914139500200208.
10
Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.利用肿瘤表型、组织学肿瘤分布和乳房X线摄影表现来解释筛查发现和临床发现的乳腺癌之间的生存差异。
APMIS. 2014 Aug;122(8):699-707. doi: 10.1111/apm.12294.

引用本文的文献

1
Outcomes for patients with the same disease treated inside and outside of randomized trials: a systematic review and meta-analysis.随机试验内外治疗同一种疾病的患者的结局:系统评价和荟萃分析。
CMAJ. 2014 Nov 4;186(16):E596-609. doi: 10.1503/cmaj.131693. Epub 2014 Sep 29.
2
Screening for breast cancer with mammography.通过乳房X线摄影术筛查乳腺癌。
Cochrane Database Syst Rev. 2013 Jun 4;2013(6):CD001877. doi: 10.1002/14651858.CD001877.pub5.
3
Mammography-based screening program: preliminary results from a first 2-year round in a Brazilian region using mobile and fixed units.

本文引用的文献

1
Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves.与主动前来者相比,接受或拒绝乳房筛查邀请的人群。
J Epidemiol Community Health. 1980 Mar;34(1):19-22. doi: 10.1136/jech.34.1.19.
2
Trial of early detection of breast cancer: description of method.乳腺癌早期检测试验:方法描述
Br J Cancer. 1981 Nov;44(5):618-27. doi: 10.1038/bjc.1981.246.
3
Screening for breast cancer: the Swedish trial.
Radiology. 1981 Jan;138(1):219-22. doi: 10.1148/radiology.138.1.7005939.
基于乳腺 X 光摄影的筛查项目:巴西某地区使用移动和固定设备进行的首轮 2 年周期的初步结果。
BMC Womens Health. 2012 Oct 2;12:32. doi: 10.1186/1472-6874-12-32.
4
Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate.参与随机对照试验的患者与接受类似干预但未参与试验的类似患者的结局比较。
Cochrane Database Syst Rev. 2008 Jul 16;2008(3):MR000009. doi: 10.1002/14651858.MR000009.pub4.
5
Systematic review to determine whether participation in a trial influences outcome.进行系统评价以确定参与试验是否会影响结果。
BMJ. 2005 May 21;330(7501):1175. doi: 10.1136/bmj.330.7501.1175.
6
Mammographic screening in older women. Is it worthwhile?老年女性的乳腺钼靶筛查。值得吗?
Drugs Aging. 1997 Feb;10(2):69-79. doi: 10.2165/00002512-199710020-00001.
7
Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme.65岁以上女性的乳腺钼靶筛查:奈梅亨项目的早期结果。
Br J Cancer. 1996 Dec;74(11):1838-42. doi: 10.1038/bjc.1996.640.
4
The Edinburgh randomised trial of screening for breast cancer: description of method.爱丁堡乳腺癌筛查随机试验:方法描述
Br J Cancer. 1984 Jul;50(1):1-6. doi: 10.1038/bjc.1984.132.
5
Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981.通过现代乳腺钼靶摄影进行大规模筛查降低乳腺癌死亡率。奈梅亨项目的初步结果,1975 - 1981年
Lancet. 1984 Jun 2;1(8388):1222-4. doi: 10.1016/s0140-6736(84)91703-3.
6
Periodic breast cancer screening in reducing mortality from breast cancer.定期乳腺癌筛查可降低乳腺癌死亡率。
JAMA. 1971 Mar 15;215(11):1777-85.
7
Impact of efforts to increase participation in repetitive screenings for early breast cancer detection.为提高早期乳腺癌检测重复性筛查参与度所做努力的影响。
Am J Public Health. 1972 Mar;62(3):328-36. doi: 10.2105/ajph.62.3.328.
8
Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons.
Breast Cancer Res Treat. 1986;8(1):45-54. doi: 10.1007/BF01805924.
9
Exploration of factors affecting mammography behaviors.
Prev Med. 1988 Jul;17(4):412-22. doi: 10.1016/0091-7435(88)90040-0.
10
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.乳腺钼靶筛查与乳腺癌死亡率:马尔默乳腺钼靶筛查试验
BMJ. 1988 Oct 15;297(6654):943-8. doi: 10.1136/bmj.297.6654.943.